Your browser doesn't support javascript.
loading
A phase 2, multicenter, placebo-controlled study of single-dose squaric acid dibutyl ester to reduce frequency of outbreaks in patients with recurrent herpes labialis.
Chang, Anne Lynn S; Honari, Golara; Guan, Linna; Zhao, Ludan; Palli, Maria Alora; Horn, Thomas D; Dudek, Arkadiusz Z; McTavish, Hugh.
Afiliação
  • Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
  • Honari G; Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
  • Guan L; Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
  • Zhao L; Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
  • Palli MA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
  • Horn TD; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Squarex, LLC, Pine Springs, Minnesota.
  • Dudek AZ; Squarex, LLC, Pine Springs, Minnesota.
  • McTavish H; Squarex, LLC, Pine Springs, Minnesota. Electronic address: hmctavish@squarex-pharma.com.
J Am Acad Dermatol ; 83(6): 1807-1809, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32289388
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Ciclobutanos / Prevenção Secundária / Exacerbação dos Sintomas / Herpes Labial Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Ciclobutanos / Prevenção Secundária / Exacerbação dos Sintomas / Herpes Labial Idioma: En Ano de publicação: 2020 Tipo de documento: Article